Powered by the Evidence-based Practice Centers
Evidence Reports All of EHC
Evidence Reports All of EHC



Detection of Associations Between Trial Quality and Effect Sizes

Research Report Jan 5, 2012
Download PDF files for this report here.

Page Contents

People using assistive technology may not be able to fully access information in these files. For assistance, please contact us.

Errata: On January 10, 2012, the report was reposted to correct an error on page ES-2. The last sentence of the third paragraph was corrected to say: “A negative effect size difference indicated that trials meeting quality criteria (high-quality trials) reported smaller effect sizes and a ROR less than 1 indicates that high-quality trials reported a smaller treatment effect compared to those trials that did not meet the quality criteria.”

Structured Abstract


To examine associations between a set of trial quality criteria and effect sizes and to explore factors influencing the detection of associations in meta-epidemiological datasets.

Data sources

The analyses are based on four meta-epidemiological datasets. These datasets consist of a number of meta-analyses; each contained between 100 and 216 controlled trials. These datasets have "known" qualities, as they were used in published research to investigate associations between quality and effect sizes. In addition, we created datasets using Monte Carlo simulation methods to examine their properties.

Review methods

We identified treatment effect meta-analyses and included trials and extracted treatment effects for four meta-epidemiological datasets. We assessed quality and risk of bias indicators with 11 Cochrane Back Review Group (CBRG) criteria. In addition, we applied the Jadad criteria, criteria proposed by Schulz (e.g., allocation concealment), and the Cochrane Risk of Bias tool. We investigated the effect of individual criteria and quantitative summary scores on the reported treatment effect sizes. We explored potential reasons for differences in associations across different meta-epidemiological datasets, clinical fields and individual meta-analyses. We investigated factors that influence the power to detect associations between quality and effect sizes in Monte Carlo simulations.


Associations between quality and effect sizes were small, e.g. the ratio of odds ratios (ROR) for unconcealed (vs. concealed) trials was 0.89 (95% CI: 0.73, 1.09, n.s.), but consistent across the CBRG criteria. Based on a quantitative summary score, a cut-off of six or more criteria met (out of 11) differentiated low- and high-quality trials best with lower quality trials reporting larger treatment effects (ROR 0.86, 95% CI: 0.70, 1.06, n.s.). Results for evidence of bias varied between datasets, clinical fields, and individual meta-analyses. The simulations showed that the power to detect quality effects is, to a large extent, determined by the degree of residual heterogeneity present in the dataset.


Although trial quality may explain some amount of heterogeneity across trial results in meta-analyses, the amount of additional heterogeneity in effect sizes is a crucial factor in determining when associations between quality and effect sizes can be detected. Detecting quality moderator effects requires more statistically powerful analyses than are employed in most investigations.

Project Timeline

Detection of Associations Between Trial Quality and Effect Sizes

Dec 6, 2010
Topic Initiated
Jan 5, 2012
Research Report
Page last reviewed November 2017
Page originally created November 2017

Internet Citation: Research Report: Detection of Associations Between Trial Quality and Effect Sizes. Content last reviewed November 2017. Effective Health Care Program, Agency for Healthcare Research and Quality, Rockville, MD.

Select to copy citation